Myriad Genetics, Inc. Share Price
Equities
MYGN
US62855J1043
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.18 USD | +1.11% | -1.73% | -5.02% |
03-20 | Myriad Genetics Gets US Patent for SneakPeek Snap Device | MT |
02-27 | Transcript : Myriad Genetics, Inc., Q4 2023 Earnings Call, Feb 27, 2024 |
Sales 2024 * | 828M 66.28B | Sales 2025 * | 897M 71.77B | Capitalization | 1.64B 132B |
---|---|---|---|---|---|
Net income 2024 * | -91M -7.28B | Net income 2025 * | -64M -5.12B | EV / Sales 2024 * | 1.96 x |
Net cash position 2024 * | 21.96M 1.76B | Net Debt 2025 * | 10.91M 874M | EV / Sales 2025 * | 1.85 x |
P/E ratio 2024 * |
-19.6
x | P/E ratio 2025 * |
-29.3
x | Employees | 2,700 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.65% |
Latest transcript on Myriad Genetics, Inc.
1 day | +1.11% | ||
1 week | -1.73% | ||
Current month | -14.73% | ||
1 month | -15.05% | ||
3 months | -18.18% | ||
6 months | +30.70% | ||
Current year | -5.02% |
Managers | Title | Age | Since |
---|---|---|---|
Paul Diaz
CEO | Chief Executive Officer | 61 | 12/08/20 |
Scott Leffler
DFI | Director of Finance/CFO | 49 | 01-28 |
Dale Muzzey
CTO | Chief Tech/Sci/R&D Officer | 44 | 31/03/14 |
Members of the board | Title | Age | Since |
---|---|---|---|
S. Phanstiel
CHM | Chairman | 65 | 15/09/09 |
Paul Bisaro
BRD | Director/Board Member | 63 | 30/10/22 |
Dan Spiegelman
BRD | Director/Board Member | 65 | 26/05/20 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.24% | 16 M€ | -8.49% | ||
0.26% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 18.18 | +1.11% | 518,695 |
25/04/24 | 17.98 | -3.49% | 582,160 |
24/04/24 | 18.63 | +0.16% | 481,133 |
23/04/24 | 18.6 | +0.59% | 508,160 |
22/04/24 | 18.49 | -0.05% | 485,015 |
Delayed Quote Nasdaq, April 26, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.02% | 1.64B | |
+0.89% | 12.8B | |
-10.29% | 7.61B | |
-1.16% | 4.51B | |
+5.74% | 4.49B | |
-50.70% | 3.3B | |
+12.21% | 2.73B | |
-16.13% | 2.02B | |
-11.50% | 1.73B | |
-8.80% | 1.53B |
- Stock Market
- Equities
- MYGN Stock